LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF
University of Massachusetts Chan Medical School · Johns Hopkins University · +2 more institutions
Abstract
Toll-IL-1-resistance (TIR) domain-containing adaptor-inducing IFN-beta (TRIF)-related adaptor molecule (TRAM) is the fourth TIR domain-containing adaptor protein to be described that participates in Toll receptor signaling. Like TRIF, TRAM activates interferon regulatory factor (IRF)-3, IRF-7, and NF-kappaB-dependent signaling pathways. Toll-like receptor (TLR)3 and 4 activate these pathways to induce IFN-alpha/beta, regulated on activation, normal T cell expressed and secreted (RANTES), and gamma interferon-inducible protein 10 (IP-10) expression independently of the adaptor protein myeloid differentiation factor 88 (MyD88). Dominant negative and siRNA studies performed here demonstrate that TRIF functions…
Citation impact
- FWCI
- 23.95
- Percentile
- 100%
- References
- 61
Authors
9- KAKatherine A. FitzgeraldCorresponding
University of Massachusetts Chan Medical School
- DCDaniel C. Rowe
University of Massachusetts Chan Medical School
- BBBetsy Barnes
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
- DRDaniel R. Caffrey
Pfizer (United States)
- AVAlberto Visintin
University of Massachusetts Chan Medical School
Topics & keywords
- TRIF
- Toll
- TLR4
- Signal transduction
- Toll-like receptor
- Cell biology
- NFKB1
- Biology